Skip to main content
. 2016 Sep 29;2016:6124059. doi: 10.1155/2016/6124059

Table 4.

Clinical stage I and frequency.

1-2/day 3–5/day 6–10/day >10/day
Type I 0 0 0 0
Type II 6 (4.5%) 6 (4.5%) 0 0
Type III 4 (3%) 4 (3%) 4 (3%) 0
Type IV 4 (3%) 26 (19.6%) 10 (7.5%) 4 (3%)
Type V 6 (4.5%) 16 (12.12%) 16 (12.12%) 2 (1.5%)
Combined 4 (3%) 16 (12.12%) 2 (1.5%) 0

χ 2 = 25.537; p = 0.0135 SIG.